Ondansetron prevents intraoperative nausea and vomiting after spinal anesthesia in women undergoing cesarean section

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100048254

Enrollment

Unknown

Registered

2021-07-05

Start date

2021-06-30

Completion date

Unknown

Last updated

2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group 1:0.75mg·kg-1·ondansetron

Group 2:normal saline

Eligibility

Sex/Gender

Female

Age

20 Years to 35 Years

Inclusion criteria

Inclusion criteria: Aged 20-35 years, gestational weeks 37-42 weeks.

Exclusion criteria

Exclusion criteria: Patients with hypertension and fetal distress.

Design outcomes

Primary

Measure	Time frame
Hemodynamic index;Complications;Use of vasoactive drugs before delivery of the fetus;Umbilical arterial blood gas;Fetal heart rate changes;	—

Countries

China

Contacts

Public ContactZhang Wangping

Wenzhou Central Hospital

zhang650679@163.com+86 13757370679

Outcome results